Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May;22(5):1179-1187.
doi: 10.1016/j.hrthm.2024.08.051. Epub 2024 Aug 27.

Atrial fibrillation burden: Stepping beyond the categorical characterization

Affiliations
Review

Atrial fibrillation burden: Stepping beyond the categorical characterization

Ioannis Doundoulakis et al. Heart Rhythm. 2025 May.

Abstract

Traditional classifications categorize atrial fibrillation (AF) into paroxysmal, persistent, or permanent, but recent advancements in monitoring have revealed AF as a continuous variable, challenging existing paradigms. AF burden, defined basically as the amount of time spent in AF during a monitored period, has emerged as a crucial metric. This review assesses the evolving landscape of AF burden and its measurement methods, diagnostic modalities, and impact on outcomes. Guidelines suggest individualized approaches, combining AF burden with clinical scores (CHA2DS2-VASc), but studies have challenged this. Addressing the impact of AF burden on patients' quality of life before or after ablation is also crucial. Although continuous monitoring technologies offer promising avenues, the field faces challenges, such as defining clinically relevant thresholds. Future research should focus on refining these, designing trials centered around AF burden, and evaluating the efficacy of interventions in reducing AF burden, ultimately paving the way for personalized management strategies.

Keywords: Atrial fibrillation; Burden; Quality of life; Smartwatch; Stroke.

PubMed Disclaimer

Conflict of interest statement

Disclosures Dr Sorgente is a consultant for Biosense Webster, Medtronic, Biotronik, and MicroPort. Dr Sarkozy is a consultant for Biosense Webster, Medtronic, Biotronik, and MicroPort. Dr Boriani reported small speaker fees from Bayer, Boehringer Ingelheim, Boston Scientific, Daiichi Sankyo, Janssen, and Sanofi. Dr Boveda consults for Medtronic, Boston Scientific, MicroPort, and Zoll. Dr Chierchia received compensation for teaching purposes and proctoring from Medtronic, Abbott, Biotronik, and Boston Scientific. Dr Tsiachris received compensation for teaching purposes and proctoring from AF Solutions, Medtronic, Boston Scientific, Biosense Webster, Pfizer, and Winmedica. Dr de Asmundis received research grants on behalf of the center from Biotronik, Medtronic, Abbott, LivaNova, Boston Scientific, and Philips and compensation for teaching purposes and proctoring from Medtronic, Abbott, Biotronik, LivaNova, Boston Scientific, and Daiichi Sankyo. The other authors have no conflicts of interest to disclose.

MeSH terms

LinkOut - more resources